The Largest, Most Active Patient Communities
Activate highly engaged patients both in-community and across other channels to capture patient sentiment, treatment concerns, and unmet needs.
Reach opted-in patients with chronic and rare conditions
The most effective way to engage 30M+ annual visitors across 80+ communities and 15+ therapeutic areas while they are actively seeking to learn about treatment options.
Don’t see a community for your treatment’s condition?
We’ve partnered with more than 40 leading manufacturers to launch new communities, including for rare disease, oncology, dermatology, neurology, and Spanish language.
On average, members are 50 percent more likely to engage in specialty care, and 45 percent indicate that they have discussed treatment with their doctor after seeing an ad in their patient community.
Source: 2024 claims analysis of MyHealthTeam community members vs. diagnosed non-members; 2025 MyHealthTeam ad exposure research.
Proximity to patient, power in connection
Communities’ media and advertising solutions provide healthcare marketers unparalleled access to highly engaged patients.
Patient Diagnosis Targeting
Reach patients in communities through hyper-targeted media aligned to specific health needs based on proprietary zero- and first-party data.
Contextual Sponsorship
Activate patients while they engage with medically reviewed content through 100% share-of voice across a condition-specific topic.
Community Extension
Extend community patient reach across the omnichannel ecosystem at scale including TV, social media, audio, and programmatic inventory.
Coordinated HCP Engagement
Drive cross-channel messaging by connecting community members (who are on average 50% more likely to engage in specialty care) with treating HCPs.
Predictive Audience Building
Uncover patients at critical moments in their health journey, including those likely to become non-adherent, for activation in-community, and across all other channels.
The power of zero-party data
A game-changer for pharmaceutical marketing, Swoop Communities by MyHealthTeam data is zero-party, meaning it is voluntarily shared by opted-in consumers in a privacy-compliant manner.
Expand reach to support patient engagement needs
Communities help brands throughout the product lifecycle find ideal patients at critical points in their health journey.
Community Launch
Partner with us to launch a new community where patients can access medically reviewed content and connect with others. We’ve successfully partnered with more than 40 brands to help them exclusively connect with patients actively seeking treatment information. See our full list of communities here.
Patient Education
Empower patients to take action through branded or unbranded articles, videos, virtual experiences, events, and resource centers that drive engagement.
Clinical Trial Recruitment
Surface your trial to those most likely to pass screening based on diagnosis, treatments, and location, leading to higher randomization rates and recruitment success.
Research and Insights
Go beyond traditional research with publishable surveys, social listening, and rapid insights from our opted-in patient communities, providing a deeper understanding of real-world patient experiences and uncovering unmet needs.
Uncover unique patient insights
Communities research has been featured at more than 35 leading medical conferences covering health equity, treatment satisfaction, disease burden, and more.
Communities
Patient Reported Impact of Psoriasis and Desired Treatment Outcomes
For this research presented at the 2025 Fall Clinical Dermatology Conference, 98 members of MyPsoriasisTeam living with psoriasis were interviewed to better understand patient-desired outcomes and help dermatologists develop more effective approaches to treatment.
Communities
Beyond the Diagnosis: Exploring the Emotional, Physical, and Financial Toll of Lung Cancer
This research underscores the urgent need for a more patient-first approach to lung cancer care.
Communities
Patients share Experience With Ruxolitinib Cream in Vitiligo
Understanding real-world experiences with a recently approved FDA vitiligo treatment helps dermatologists set realistic expectations with their patients, which can foster increased adherence
Interested in conducting your own research?
From rapidly deployed surveys to social listening and deep insights, we help brands better understand their patients.
Customer Testimonials
“[Communities] brings together patients, medical experts, and pharma companies to share condition-specific information, creating a patient engagement opportunity never before possible.”
Todd Leathers, Associate Vice President of Clinical Operations, Incyte
“The patient education we do with [Communities] helps people more effectively discuss treatment options and adherence strategies with their doctor, which leads to better shared decision-making.”
Terrie Livingston, PharmD, Head of Patient Outcomes and Solutions, EDM Serono
“Our joint research helps identify and address unmet needs, incorporating the patient’s voice and prioritizing their concerns – which sometimes differ from those of HCPs.”
Javier Zambrano, M.D., Medical Director of Gastroenterology, AbbVie
“Together, we provide patients actionable information when and where they’re talking about their health and seeking trusted expertise. This improves the patient journey and outcomes.”
Evangelia Pateraki, Head of Axial Spondyloarthritis, UCB
Recognized as an industry leader
Award-winning people, products, and innovations.
Spring 2026 Digital Health Awards
WINNER
Spring 2025 Digital Health Awards Winners
WINNER
Chief The New Era of Leadership 2025
WINNER
Fall 2024 Digital Health Awards
WINNER
Resources
Communities
Better Together: Swoop and MyHealthTeam Overview
Combining the power of the largest provider of programmatic health audiences with the largest U.S. patient communities to deliver unparalleled scale and patient engagement.
Communities
The Rare Disease Marketing Guide: 5 Strategies Every Pharma Marketer Needs To Know for Patient Engagement
R&D in rare diseases has skyrocketed. Thirty percent of today’s R&D pipeline is in rare diseases, and 40 percent of overall pipeline growth since 2013 is due to rare diseases.
Communities
Swoop Expands Patient-Centric Engagement with Acquisition of MyHealthTeam, a Leading Opted-In Patient Community in the U.S.
Swoop announces its acquisition of MyHealthTeam, the creator of one of the largest and most highly engaged opted-in patient social networks in the U.S.
Engage patients where they are
A solution for every need
Impactful, targeted, and compliant marketing outcomes through powerful data and artificial intelligence.
SOLUTION
We’re helping connect consumers with vital health information through a methodology that minimizes risk.
SOLUTION
Uncover the most relevant patients for your brand.
SOLUTION
Go beyond traditional NPI segmentation and PLD reporting by quantifying every HCP’s brand value.
SOLUTION
Predict tomorrow’s target today to reach DTC and HCP audiences before health events occur.
SOLUTION
Unify campaign optimization across data-driven linear, addressable, and connected TV.
SOLUTION
Engage the largest opted-in patient communities across 80+ rare and chronic conditions.
SOLUTION
Accelerate decision-making through actionable insights from our AI and data-driven ecosystem.
SOLUTION
Accelerate therapy adoption with intelligence that helps patients start treatment without delays and stay on therapy.
SOLUTION
Transform customer engagement on brand.com and unlock valuable first-party data with conversational AI.